Breast cancer is a major disease with high morbidity and mortality in women worldwide.
Increased use of imaging biomarkers has been shown to add more information with clinical …

Imaging is paramount for the early detection and clinical staging of breast cancer, as well as
to inform management decisions and direct therapy. PET–MRI is a quantitative hybrid …

Numerous imaging modalities may be used for the staging of women with advanced breast
cancer. Although bone scintigraphy and multiplanar-CT are the most frequently used tests …

The combination of PET and MRI is one of the recent advances of hybrid imaging. Yet to
date, the adoption rate of PET/MRI systems has been rather slow. This seems to be partially …

Objectives To calculate the pooled diagnostic performances of whole-body [18F] FDG
PET/MR in M staging of [18F] FDG-avid cancer entities. Methods A diagnostic meta-analysis …

Pancreatic tumor segmentation is a difficult task due to the high variable shape, small size
and hidden position of organs in patients for adaptive radiation therapy plan. To address the …

Introduction By performing a systematic review and meta-analysis, the diagnostic value of 18
F-FDG PET/MRI in breast lesions, lymph nodes, and distant metastases was assessed, and …

Purpose To compare the diagnostic performance of 18-FDG-PET/MR and PET/CT for the N-
and M-staging of breast cancer. Methods and materials Two independent readers blinded to …

Purpose PET/MRI was introduced for clinical use in 2011 and is now an established
modality for the imaging of brain and certain pelvic cancers, whereas clinical use for the …

BACKGROUND. The available evidence on the use of FDG PET/MRI performed using an
integrated system in patients with cancer has grown substantially. OBJECTIVE. The purpose …